Cipher Pharmaceuticals Inc.
CPHRF
$10.35
-$0.12-1.11%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.07M | 12.51M | 12.22M | 12.83M | 13.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.07M | 12.51M | 12.22M | 12.83M | 13.38M |
| Cost of Revenue | 2.37M | 2.21M | 2.30M | 2.35M | 2.50M |
| Gross Profit | 9.70M | 10.30M | 9.91M | 10.49M | 10.88M |
| SG&A Expenses | 3.18M | 2.90M | 3.68M | 3.71M | 4.09M |
| Depreciation & Amortization | 1.79M | 1.81M | 1.81M | 1.80M | 1.81M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.33M | 6.91M | 7.79M | 7.86M | 8.39M |
| Operating Income | 4.73M | 5.60M | 4.43M | 4.97M | 4.99M |
| Income Before Tax | 3.64M | 4.95M | 4.61M | 4.26M | 6.41M |
| Income Tax Expenses | -369.00K | -1.21M | -8.70M | -1.24M | 512.00K |
| Earnings from Continuing Operations | 4.01M | 6.16M | 13.31M | 5.50M | 5.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.01M | 6.16M | 13.31M | 5.50M | 5.89M |
| EBIT | 4.73M | 5.60M | 4.43M | 4.97M | 4.99M |
| EBITDA | 6.44M | 7.33M | 5.95M | 6.77M | 6.80M |
| EPS Basic | 0.16 | 0.24 | 0.52 | 0.22 | 0.23 |
| Normalized Basic EPS | 0.10 | 0.12 | 0.12 | 0.10 | 0.15 |
| EPS Diluted | 0.15 | 0.24 | 0.51 | 0.21 | 0.22 |
| Normalized Diluted EPS | 0.09 | 0.12 | 0.12 | 0.10 | 0.15 |
| Average Basic Shares Outstanding | 25.40M | 25.28M | 25.60M | 25.37M | 25.87M |
| Average Diluted Shares Outstanding | 25.99M | 25.80M | 26.10M | 25.95M | 26.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |